Pathological cycling in addiction (Koob, Neuron, 2008)

Slides:



Advertisements
Similar presentations
Enhancement of auditory fear conditioning after housing in a complex environment is attenuated by prior treatment with amphetamine Lisa A. Briand, Terry.
Advertisements

How do drugs of abuse rewire the motivational circuitry?
Interactions Between Reward and Stress Systems
The Addicted Synapse Katie Malanson.
Nora D. Volkow, M.D. Director National Institute on Drug Abuse National Institutes of Health Overlapping Neuronal Circuits In.
DRUG ABUSE & MENTAL ILLNESS: Progress in Understanding COMORBIDITY DRUG ABUSE & MENTAL ILLNESS: Progress in Understanding COMORBIDITY Donald R. Vereen,
Wanting Things How Your Brain Works - Week 8 Dr. Jan Schnupp HowYourBrainWorks.net.
Addiction: Transition from Molecular to Behavioral Understanding John Neumaier, M.D., Ph.D. Department of Psychiatry Harborview Medical Center and University.
Social defeat stress, sensitization, and intravenous cocaine self-administration By Jasmine Yap and Klaus Miczek.
Drugs of Addiction and Alcohol Effects on the Brain By Jonathan Godon & Eric Albuquerque Science 8-4.
Drug Addiction. History: Opiate Effects Characteristics of drug addiction: Characteristics of drug addiction: Tolerance: decreased drug effect w/ repeated.
Topics for this lecture Drugs - All drugs of abuse induce dopamine release (?) The anatomy of the reward pathway defines the road to drug abuse (?) Cellular.
MGlu5 receptor antagonists are neuroprotective against methamphetamine toxicity THDATGFAP Saline METH +MPEP +SIB-1893 Saline Methamphetamine (5 mg/kg x.
STRESS AND PLASTICITY.
Neurobiology of drug action and
Long term potentiation (LTP) of an excitatory synaptic inputs is input specific.
The Neurobiology of Addiction
Schizophrenia positive symptoms negative symptoms anx/dep aggressive symptoms cognitive symptoms 10-1 Stahl S M, Essential Psychopharmacology (2000)
From: Swanson et al. Nat Rev Drug Disc Activation of mGlu2/3 receptors inhibits excitatory synaptic ransmission with greater potency in the amygdala.
Bringing the Full Power of Science to Bear on Bringing the Full Power of Science to Bear on NIDA NATIONAL INSTITUTE ON DRUG ABUSE Drug Abuse & Addiction.
Models of addiction: role of dopamine and other neurobiological substrates Paul E. M. Phillips, Ph.D. Department of Psychiatry and Behavioral Sciences.
Neurobiology of drug action and addiction Richard Palmiter Dept Biochemistry.
Drug Tolerance Cross Tolerance Metabolic Tolerance
Synaptic plasticity Basic Neuroscience NBL 120. classical conditioning CS (neutral) - no response US - UR After pairing: CS - CR.
Dysregulation of glutamate homeostasis in the NAc core underlies relapse (Knackstedt et al., Biol. Psychiatry, 2009)
Multiple Neuronal Systems Thought to be Involved in Nicotine Dependence Frank Vocci, Ph.D. Director Division of Treatment Research and Development National.
Neurocircuitry of Relapse. Circuitry Mediating Motivated Behavior VTA dopamine Basal Ganglia Anterior Cingulate Ventral Orbital Amygdala Hippocampus Opioids.
Disrupting Reconsolidation of Drug Memories: Potential Treatment Target for Attenuating Drug- Seeking and Relapse Elicited by Drug-Associated Stimuli Barry.
Stress and Drug Abuse Primary interaction of stress and drug abuse is relapse. Can stress cause initiation of drug use/abuse?
Synaptic Transmission
Neuro Unit 5: How do our choices change our brains?
Neurological Disorders Lesson 5.2 How do drugs alter synaptic transmission? Human Brain Rat Brain.
Human Brain. Introduction nMechanisms of control of behavior u Reflex u Involuntary u Voluntary nUnderstanding from analysis of neural diseases.
Metabotropic Glutamate 5 Receptors: Role in drug self-administration and in regulating the activity of brain reward systems Paul J. Kenny, Ph.D The Scripps.
Drug addiction – learning gone wild? Dr Stuart McLaren MRCPsych. Phase 1 Psychopharmacology module
The Neurobiology of Free Will In National Institute on Drug Abuse
Orexin/Hypocretin enhances synaptic strength in VTA dopamine neurons Stephanie Borgland, Ph.D. Ernest Gallo Clinic and Research Center, UCSF.
Yavin M. Shaham, Ph.D. Behavioral Neuroscience Branch
Increased Energy “It sustains and refreshes both body and brain in the same space of time more than double the amount of work could be undergone...”
Chronic treatment with cannabinoid receptor agonist, CP 55,940, alters GLT1 expression in adolescent rats Introduction Methods Results Selected References.
Central Nervous System Stimulants Constricted Blood Vessels Constricted Blood Vessels Increased Pulse Increased Pulse Increased Blood Pressure Increased.
Advances in science have revolutionized our fundamental views of drug abuse and addiction. Science has come a long way in helping us understand how drugs.
The Neural Basis of Addiction : A Pathology of Motivation and Choice Am J Psychiatry 162 : , August 2005.
알코올 의존, 질병의 경과와 항갈망제의 사용 Industry-sponsored lecture 알코올 의존, 질병의 경과와 항갈망제의 사용 Ki, Seon Wan M.D., Ph. D. Incheon St. Mary’s Hospital Incheon, Korea.
First Marijuana Use, (Percent of Initiates) 1.5% 67% 5.5% 25 Addiction is a Developmental Disease: It Starts Early 26%
The Science of Addiction. Homelessness Crime Violence Homelessness Crime Violence Neurotoxicity AIDS, Cancer Mental illness Neurotoxicity AIDS, Cancer.
1 Addiction to tobacco Robert West University College London November
بنام خدا DR.KARIMI. DRUG ABUSE & MENTAL ILLNESS: Progress in Understanding COMORBIDITY DRUG ABUSE & MENTAL ILLNESS: Progress in Understanding COMORBIDITY.
Neural reward circuits for various drugs (cocaine, amphetamines, opiates, nicotine, and ethanol) in a sagittal section of rat brain. A limbic–extrapyramidal.
Dopamine system: neuroanatomy
Metabotropic Neurotransmitter Receptors
Conclusions & Future Directions
Adolescents and Substance Abuse
P.W. Kalivas, N. Volkow, J. Seamans  Neuron 
Guy A. Higgins, Edward M. Sellers, Paul J. Fletcher 
Motivation Not all responses can be explained by
Drug Effects Why take drugs? How do drugs influence synapses?
Psych 181: Dr. Anagnostaras Lec 12: Addiction.
Neuroscience of Addiction
The Brain on Drugs: From Reward to Addiction
Group 1 mGluR-Dependent Synaptic Long-Term Depression: Mechanisms and Implications for Circuitry and Disease  Christian Lüscher, Kimberly M. Huber  Neuron 
Guy A. Higgins, Edward M. Sellers, Paul J. Fletcher 
Group 1 mGluR-Dependent Synaptic Long-Term Depression: Mechanisms and Implications for Circuitry and Disease  Christian Lüscher, Kimberly M. Huber  Neuron 
Christian Lüscher, Robert C. Malenka  Neuron 
Brain Reward Circuitry
Marco Pignatelli, Antonello Bonci  Neuron 
Proposed mechanism for nicotinic modulation of striatal synaptic plasticity following amphetamine self-administration. Proposed mechanism for nicotinic.
Presentation transcript:

Pathological cycling in addiction (Koob, Neuron, 2008)

DA release (% of basal) Drugs of abuse increase synaptic DA in the Nucleus Accumbens (Di Chiara and Imperato, Proc. Natl. Acad. Sci., 1988) ethanol nicotine

Limbic motor subcircuit Dorsal-striatal motor subcircuit (motor habits)

Cocaine self-administration heroin Glutamate release associated with addiction (You et al., J. Neurosci., 2007; LaLumiere and Kalivas, J. Neurosci. 2008) Nac core

Glutamate Receptor Families AMPAKainateNMDAMetabotropic GluR1 GluR2 GluR3 GluR4 GluR5 GluR6 GluR7 KA1 KA2 NMDAR1 NMDAR2A NMDAR2B NMDAR2C NMDAR2D mGluR1 mGluR5 mGluR2 mGluR3 mGluR4 mGluR6 mGluR7 mGluR8 Go Gi, Gq NMDAR3

Control LTP LTP and LTD of excitatory synaptic transmission as a substrate for associative learning

Drugs of abuse induce LTP at excitatory synapses on DAergic neurons in the VTA (Kauer and Malenka, Nat. Rev. Neurosci. 8, 844, 2007)

NAc Bidirectional loss of synaptic plasticity at the PFC/NAc core synapses following chronic cocaine (Mussawi et al., Nat. Neurosci., 2009) LTP LTD

Transiction to addiction is associated with a persistent impairment in NMDA-dependent LTD in the NAcc core Kasanetz F., Deroche-Gemonet V., Berson N., Balado E., Lafourcade M., Manzoni O., Piazza P.V. Science 328, 1709, 2010

The “perfect” drug: 1. inhibits the reinforcing properties of drugs and associated cues 2. reinstates the mechanisms of control by the PFC over the VTA-NAc 3. interferes with maladaptive mechanisms leading to hedonic allostasis 4. relieves physical and motivational withdrawal symptoms 5. prevents relapse in response to drug priming, context, and stress 6. has an impact on the negative reinforcement generated by the stress neural circuit (extended amygdala)

mGlu1 mGlu5 mGlu2 mGlu3 mGlu4 mGlu6 mGlu7 mGlu8

mGlu5 receptors: potential targets for The treatment of addiction MAPK, PI-3-K GSGS

Fenobam ADX10059 ADX48621 STX107 AZD2516 AFQ056 Negative allosteric modulators of mGlu5 receptors: Fragile X, GERD, migraine, nicotine addiction, Parkinson’s disease/L-DOPA-induced dyskinesias

Reinforcing effects of cocaine are absent in mGlu5 knockout mice (Chiamulera et al., Nature, 2001)

1. Amplification of PF/VTA excitatory synapses by mGlu5 receptors Activation of mGlu5 receptors is required for incentive motivation for the reinforcer (Markou, Biol. Psych. 2007)

Extinction training after cocaine self-administration lowers surface mGlu5 receptors in the Nacc core to inhibit drug seeking mGlu5 Knackstedt et al., J. Neurosci. 30, 2010

mGlu5 receptor blockade reduces methamphetamine reinforcement and reimstatement (Gass et al., Neuropsychopharm. 34, 2008)

mGlu5 receptor blockade is protective against Methamphetamine (“Shabu”) toxicity

Lewy bodies in the substantia nigra of a Parkinsonian patient Intracytoplasmic inclusions after methamphetamine injection Forno et al., 1996 Fornai et al., 2003 Saline Methamphetamine Ubiquitin  -Synuclein Parkin Fornai et al., 2003